UiPath price target raised to $20 from $16 at BMO Capital

BMO Capital raised the firm’s price target on UiPath to $20 from $16 but keeps a Market Perform rating on the shares. The analyst cites the company’s Q4 upside across all metrics, including ARR and profitability, also noting that UiPath has "upside tension" to its FY24 guidance. BMO is "bullish" on UiPath’s technology, positioning, and growth potential of the RPA market segment, but its neutral stance reflects the firm’s concerns about inflation and interest rates, the firm tells investors in a research note.